Publicacións en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (200)

2021

  1. Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial

    Infectious Diseases and Therapy, Vol. 10, Núm. 2, pp. 775-788

  2. Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study)

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 12, pp. 3263-3271

  3. Feasibility of Implementing Long-Acting Injectable Antiretroviral Therapy to Treat HIV: A Survey of Health Providers from the 13 Countries Participating in the ATLAS-2M Trial

    AIDS Research and Human Retroviruses, Vol. 37, Núm. 3, pp. 207-213

  4. Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antivirals

    Liver International, Vol. 41, Núm. 12, pp. 2885-2891

  5. Late HIV diagnosis among immigrants in Spain vs. native-born Spaniards, 2010-15

    European Journal of Public Health, Vol. 31, Núm. 6, pp. 1123-1128

  6. Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

    Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1678-1684

  7. Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study

    BMC Infectious Diseases, Vol. 21, Núm. 1

  8. Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation

    Journal of acquired immune deficiency syndromes (1999), Vol. 86, Núm. 4, pp. 490-495